日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life

肺动脉高压全球患者调查:对健康相关生活质量的生理和心理社会影响

Bunclark, Katherine; Newman, Joseph; Ghani, Hakim; Munagala, Shiv; Otter, Eva; Fischer, Gerald; Kurzyna, Marcin; Meszaros, Gergely; Stone, Millicent; Moledina, Shahin; Howard, Luke; Gin-Sing, Wendy; Ferrari, Pisana; Beghetti, Maurice; Toshner, Mark; Granato, Matt; Pepke-Zaba, Joanna

The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension

肺动脉高压全球患者调查:了解儿童肺动脉高压的隐形负担

Quyam, Sadia; Drumm, Sarah; Mungala, Shiv; Bunclark, Katherine; Fischer, Gerald; Otter, Eva; Ghani, Hakim; Gin-Sing, Wendy; Howard, Luke; Kurzyna, Marcin; Ferrari, Pisana; Macdonald, Lynsay; Newman, Joseph; Stone, Millicent; Toshner, Mark; Pepke-Zaba, Joanna; Beghetti, Maurice; Moledina, Shahin

The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3

肺动脉高压全球患者调查:第 2 组和第 3 组

Bunclark, Katherine; Newman, Joseph; Ghani, Hakim; Munagala, Shiv; Otter, Eva; Fischer, Gerald; Kurzyna, Marcin; Meszaros, Gergely; Stone, Millicent; Moledina, Shahin; Howard, Luke; Gin-Sing, Wendy; Ferrari, Pisana; Beghetti, Maurice; Toshner, Mark; Granato, Matt; Pepke-Zaba, Joanna

Digital Data Collection Reduces Terminal Digit Bias in Haemodynamic and Physical Activity Measures in Pulmonary Arterial Hypertension

数字化数据采集可减少肺动脉高压患者血流动力学和体力活动指标中的末位数字偏差

Rothman, Alexander M K; Paula-Ribeiro, Marcelle; McNally, Eleanor; Wason, James; Toshner, Mark

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension

GDF15是一种潜在的生物标志物,可用于区分肺静脉闭塞性疾病和肺动脉高压。

Prabhakar, Amit; De Bie, Eckart Mdd; DesJardin, Jacqueline T; Ghatpande, Prajakta; Gräf, Stefan; Howard, Luke S; Wort, S John; Church, Colin; Kiely, David G; Sumpena, Emily; Aung, Thin; Carter, Shenrae; Kukreja, Jasleen; Hays, Steven; Greenland, John R; Singer, Jonathan P; Wax, Michael; Wolters, Paul J; Simon, Marc A; Toshner, Mark; Lagna, Giorgio; Hata, Akiko

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study

肺动脉高压超声心动图检查指南推荐方法的实施效果:CIPHER 研究分析

Howard, Luke S; Kiely, David G; Lawrie, Allan; Maron, Bradley A; Preston, Ioana R; Rosenkranz, Stephan; Toshner, Mark; Wilkins, Martin R; Fong, Yiu-Lian; Quinn, Debbie; Stamatiadis, Dimitri; Villeneuve, Matthieu; Chin, Kelly M

Comparability, acceptability and longitudinal adherence with digital emPHasis-10 in pulmonary arterial hypertension

在肺动脉高压患者中,数字 emPHasis-10 的可比性、可接受性和长期依从性

Newman, Joseph; Varian, Frances; Hitchcock, Felicity; Burney, Rebecca; Rawlings, Gregg Harry; Harrington, John; Goh, Ze Ming; Ablott, Jenna; Kiely, David G; Armstrong, Iain; Thompson, A A Roger; Carlton, Jill; Davies, Elin Haf; Rothman, Alexander; Toshner, Mark

Reply: Use of total correlation and other information-theoretic quantities to describe distributions of clinical datasets, with reference to risk models for pulmonary endarterectomy

回复:利用总相关性和其他信息论量描述临床数据集的分布,并参考肺动脉内膜切除术的风险模型

Liley, James; Bunclark, Katherine; Toshner, Mark

A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation

关于简单地使用普通人群生物样本库研究肺动脉高压的警示,重点关注孟德尔随机化。

Woolf, Benjamin; De Bie, Eckart; McLaughlin, Vallerie; Gräf, Stefan; Toshner, Mark; Wilkins, Martin R; Rhodes, Christopher J; Burgess, Stephen

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study

伊马替尼在肺动脉高压治疗中的定位:一项剂量探索性 II 期研究

Rothman, Alexander M K; Villar, Sofia S; Middleton, Jennifer; Roussakis, Andreas A; Varian, Frances; Zafar, Hamza; Law, Martin; Apperley, Jane; Bartelink, Imke H; Said, Medhat M; Delgado-SanMartin, Juan A; Kiely, David G; Howard, Luke; Toshner, Mark; Wort, S John; Wilkins, Martin R